Tremlett H - Search Results

1

Serum proteomics in multiple sclerosis disease progression.

Tremlett H, Dai DL, Hollander Z, Kapanen A, Aziz T, Wilson-McManus JE, Tebbutt SJ, Borchers CH, Oger J, Cohen Freue GV. Tremlett H, et al. J Proteomics. 2015 Apr 6;118:2-11. doi: 10.1016/j.jprot.2015.02.018. Epub 2015 Mar 6. J Proteomics. 2015. PMID: 25753122

2

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

Tremlett HL, Oger J. Tremlett HL, et al. Neurology. 2003 Aug 26;61(4):551-4. doi: 10.1212/01.wnl.0000078885.05053.7d. Neurology. 2003. PMID: 12939437 Review.

3

Liver injury associated with the beta-interferons for MS: a comparison between the three products.

Tremlett HL, Yoshida EM, Oger J. Tremlett HL, et al. Neurology. 2004 Feb 24;62(4):628-31. doi: 10.1212/wnl.62.4.628. Neurology. 2004. PMID: 14981183 Review.

4

Elevated aminotransferases during treatment with interferon-beta for multiple sclerosis: actions and outcomes.

Tremlett HL, Oger J. Tremlett HL, et al. Mult Scler. 2004 Jun;10(3):298-301. doi: 10.1191/1352458504ms1007oa. Mult Scler. 2004. PMID: 15222695

5

Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis.

Tremlett H, Oger J. Tremlett H, et al. J Neurol. 2004 Nov;251(11):1297-303. doi: 10.1007/s00415-004-0619-5. J Neurol. 2004. PMID: 15592724 Review.

6

Disability progression in multiple sclerosis is slower than previously reported.

Tremlett H, Paty D, Devonshire V. Tremlett H, et al. Neurology. 2006 Jan 24;66(2):172-7. doi: 10.1212/01.wnl.0000194259.90286.fe. Neurology. 2006. PMID: 16434648

7

Does the season or month of birth influence disease progression in multiple sclerosis?

Tremlett HL, Devonshire VA. Tremlett HL, et al. Neuroepidemiology. 2006;26(4):195-8. doi: 10.1159/000092406. Epub 2006 Mar 28. Neuroepidemiology. 2006. PMID: 16567947

8

Is late-onset multiple sclerosis associated with a worse outcome?

Tremlett H, Devonshire V. Tremlett H, et al. Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d. Neurology. 2006. PMID: 17000960

9

Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients.

Tremlett H, Seemüller S, Zhao Y, Yoshida EM, Oger JD, Petkau J. Tremlett H, et al. Neurology. 2006 Oct 10;67(7):1291-3. doi: 10.1212/01.wnl.0000238515.27055.62. Neurology. 2006. PMID: 17030771 Clinical Trial.

10

Longitudinal follow-up of "benign" multiple sclerosis at 20 years.

Sayao AL, Devonshire V, Tremlett H. Sayao AL, et al. Among authors: tremlett h. Neurology. 2007 Feb 13;68(7):496-500. doi: 10.1212/01.wnl.0000253185.03943.66. Neurology. 2007. PMID: 17296915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters